"The Neurosciences Institute combines the latest treatments & technologies to bring you comprehensive care for brain, spine and nervous system disorders."

During the past decade, Carolinas Healthcare System Neurosciences Institute conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Carolinas Healthcare System Neurosciences Institute" #1 sponsor was "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 3 trials, followed by "Santhera Pharmaceuticals" with 2 trials sponsored, "Alexion" with 1 trials sponsored, "Cytokinetics" with 1 trials sponsored and "H. Lundbeck A/S" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Carolinas Healthcare System Neurosciences Institute" are "Amyotrophic Lateral Sclerosis" (2 trials), "Charcot-Marie-Tooth Disease" (2 trials), "Facioscapulohumeral Muscular Dystrophy" (2 trials), "ALS" (1 trials) and "Duchenne Muscular Dystrophy" (1 trials). Many other conditions were trialed in "Carolinas Healthcare System Neurosciences Institute" in a lesser frequency.

Most popular intervention types in "Carolinas Healthcare System Neurosciences Institute" are "Drug" (8 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "ACE-083" (3 trials), "Placebo" (2 trials), "ACE-083 or placebo" (1 trials), "Droxidopa capsules" (1 trials) and "Idebenone 150 mg film-coated tablets" (1 trials). Other intervention names were less common.

The vast majority of trials in "Carolinas Healthcare System Neurosciences Institute" are 6 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Carolinas Healthcare System Neurosciences Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Carolinas Healthcare System Neurosciences Institute, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Carolinas Healthcare System Neurosciences Institute, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".